NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
    2.
    发明公开
    NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS 有权
    非核苷反义转录酶抑制剂

    公开(公告)号:EP2552902A1

    公开(公告)日:2013-02-06

    申请号:EP11761856.1

    申请日:2011-03-28

    申请人: Merck Canada Inc.

    摘要: Heteroaromatic compounds of Formula I: (I) are HIV reverse transcriptase inhibitors, wherein R
    1 , R
    2 , R
    3 ; R
    4 and R
    5 are defined herein. The compounds of Formula I and their pharmaceutically acceptable salts are useful in the inhibition of HIV reverse transcriptase, the prophylaxis and treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

    摘要翻译: 式I的杂芳族化合物:(I)是HIV逆转录酶抑制剂,其中R 1,R 2,R 3; R 4和R 5如本文所定义。 式I化合物及其药学上可接受的盐可用于抑制HIV逆转录酶,预防和治疗HIV感染以及预防,延缓AIDS的发作或进展以及治疗。 化合物及其盐可以用作药物组合物中的成分,任选地与其他抗病毒剂,免疫调节剂,抗生素或疫苗组合使用。